27 related articles for article (PubMed ID: 6261943)
1. Dianhydrogalactitol induces replication-dependent DNA damage in tumor cells preferentially resolved by homologous recombination.
Zhai B; Steinø A; Bacha J; Brown D; Daugaard M
Cell Death Dis; 2018 Oct; 9(10):1016. PubMed ID: 30283085
[TBL] [Abstract][Full Text] [Related]
2. Single-agent chemotherapy for advanced adenocarcinoma of the lung. A review.
Sørensen JB; Clerici M; Hansen HH
Cancer Chemother Pharmacol; 1988; 21(2):89-102. PubMed ID: 3280154
[TBL] [Abstract][Full Text] [Related]
3. Absence of cross-resistance between two alkylating agents: BCNU vs bifunctional galactitol.
Institóris E; Szikla K; Otvös L; Gál F
Cancer Chemother Pharmacol; 1989; 24(5):311-3. PubMed ID: 2758560
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of the combination of dianhydrogalactitol, doxorubicin, and cisplatin (DAP) in patients with advanced squamous cell lung cancer.
Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK
Cancer Treat Rep; 1981; 65(5-6):517-9. PubMed ID: 7195306
[No Abstract] [Full Text] [Related]
5. Phase II evaluation of dianhydrogalactitol in advanced head and neck carcinomas.
Edmonson JH; Frytak S; Letendre L; Kvols LK; Eagan RT
Cancer Treat Rep; 1979; 63(11-12):2081-3. PubMed ID: 526941
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of dianhydrogalactitol in advanced renal cell carcinoma: a Southwest Oncology Group study.
Ratanatharathorn V; Baker LH; Balducci L; Talley RW; Hoogstraten B
Cancer Treat Rep; 1982 May; 66(5):1231-2. PubMed ID: 7083224
[No Abstract] [Full Text] [Related]
7. Phase II trial of dianhydrogalactitol in the treatment of children with refractory childhood malignancies: a report from the Children's Cancer Study Group.
Finklestein JZ; Shore N; Krivit W; Hammond D; Higgins G
Cancer Treat Rep; 1985 Nov; 69(11):1331-3. PubMed ID: 4092198
[No Abstract] [Full Text] [Related]
8. Phase II trials of hexamethylmelamine, dianhydrogalactitol, razoxane, and beta-2'-deoxythioguanosine as single agents against advanced measurable tumors of the pancreas. Gastrointestinal Tumor Study Group.
Cancer Treat Rep; 1985 Jun; 69(6):713-6. PubMed ID: 3926311
[TBL] [Abstract][Full Text] [Related]
9. Phase II evaluation of dianhydrogalactitol in lung cancer: a Southwest Oncology Group Study.
Haas CD; Baker L; Thigpen T
Cancer Treat Rep; 1981; 65(1-2):115-7. PubMed ID: 6261943
[TBL] [Abstract][Full Text] [Related]
10. [Therapy for lung cancer in view of internal medicine].
Shiraishi J; Saijo N
Kokyu To Junkan; 1993 Sep; 41(9):815-24. PubMed ID: 8210738
[No Abstract] [Full Text] [Related]
11. Chemotherapy of lung cancer.
Carter SK
Semin Oncol; 1982 Dec; 9(4 Suppl 1):40-55. PubMed ID: 6298943
[No Abstract] [Full Text] [Related]
12. New developments in the treatment of advanced lung cancer.
Straus MJ
Am Rev Respir Dis; 1979 Nov; 120(5):967-71. PubMed ID: 228574
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
